These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 24113258)
1. Non-neuronal cell responses differ between normal and Down syndrome developing brains. Kanaumi T; Milenkovic I; Adle-Biassette H; Aronica E; Kovacs GG Int J Dev Neurosci; 2013 Dec; 31(8):796-803. PubMed ID: 24113258 [TBL] [Abstract][Full Text] [Related]
2. OLIG2 over-expression impairs proliferation of human Down syndrome neural progenitors. Lu J; Lian G; Zhou H; Esposito G; Steardo L; Delli-Bovi LC; Hecht JL; Lu QR; Sheen V Hum Mol Genet; 2012 May; 21(10):2330-40. PubMed ID: 22343408 [TBL] [Abstract][Full Text] [Related]
3. Disruption of neurogenesis and cortical development in transgenic mice misexpressing Olig2, a gene in the Down syndrome critical region. Liu W; Zhou H; Liu L; Zhao C; Deng Y; Chen L; Wu L; Mandrycky N; McNabb CT; Peng Y; Fuchs PN; Lu J; Sheen V; Qiu M; Mao M; Lu QR Neurobiol Dis; 2015 May; 77():106-16. PubMed ID: 25747816 [TBL] [Abstract][Full Text] [Related]
4. Astroglia disturbances during development of the central nervous system in fetuses with Down's syndrome. Zdaniuk G; Wierzba-Bobrowicz T; Szpak GM; Stępień T Folia Neuropathol; 2011; 49(2):109-14. PubMed ID: 21845539 [TBL] [Abstract][Full Text] [Related]
5. Apoptosis of astrocytes with enhanced lysosomal activity and oligodendrocytes in white matter lesions in Alzheimer's disease. Kobayashi K; Hayashi M; Nakano H; Fukutani Y; Sasaki K; Shimazaki M; Koshino Y Neuropathol Appl Neurobiol; 2002 Jun; 28(3):238-51. PubMed ID: 12060348 [TBL] [Abstract][Full Text] [Related]
6. The developmental and aging changes of Down's syndrome cell adhesion molecule expression in normal and Down's syndrome brains. Saito Y; Oka A; Mizuguchi M; Motonaga K; Mori Y; Becker LE; Arima K; Miyauchi J; Takashima S Acta Neuropathol; 2000 Dec; 100(6):654-64. PubMed ID: 11078217 [TBL] [Abstract][Full Text] [Related]
7. Diversity of glial cell components in pilocytic astrocytoma. Tanaka Y; Sasaki A; Ishiuchi S; Nakazato Y Neuropathology; 2008 Aug; 28(4):399-407. PubMed ID: 18312545 [TBL] [Abstract][Full Text] [Related]
8. [Molecular Mechanism Underlying Abnormal Differentiation of Neural Progenitor Cells in the Developing Down Syndrome Brain]. Kurabayashi N; Sanada K Yakugaku Zasshi; 2017; 137(7):795-800. PubMed ID: 28674289 [TBL] [Abstract][Full Text] [Related]
9. Neurogenesis impairment and increased cell death reduce total neuron number in the hippocampal region of fetuses with Down syndrome. Guidi S; Bonasoni P; Ceccarelli C; Santini D; Gualtieri F; Ciani E; Bartesaghi R Brain Pathol; 2008 Apr; 18(2):180-97. PubMed ID: 18093248 [TBL] [Abstract][Full Text] [Related]
10. Olig2-positive cells in glioneuronal tumors show both glial and neuronal characters: the implication of a common progenitor cell? Matsumura N; Yokoo H; Mao Y; Yin W; Nakazato Y Neuropathology; 2013 Jun; 33(3):246-55. PubMed ID: 23025580 [TBL] [Abstract][Full Text] [Related]
11. Progeny of Olig2-expressing progenitors in the gray and white matter of the adult mouse cerebral cortex. Dimou L; Simon C; Kirchhoff F; Takebayashi H; Götz M J Neurosci; 2008 Oct; 28(41):10434-42. PubMed ID: 18842903 [TBL] [Abstract][Full Text] [Related]
12. Olig transcription factors are expressed in oligodendrocyte and neuronal cells in human fetal CNS. Jakovcevski I; Zecevic N J Neurosci; 2005 Nov; 25(44):10064-73. PubMed ID: 16267213 [TBL] [Abstract][Full Text] [Related]
13. Assessment of radial glia in the frontal lobe of fetuses with Down syndrome. Baburamani AA; Vontell RT; Uus A; Pietsch M; Patkee PA; Wyatt-Ashmead J; Chin-Smith EC; Supramaniam VG; Donald Tournier J; Deprez M; Rutherford MA Acta Neuropathol Commun; 2020 Aug; 8(1):141. PubMed ID: 32819430 [TBL] [Abstract][Full Text] [Related]
14. Abnormal development of the inferior temporal region in fetuses with Down syndrome. Guidi S; Giacomini A; Stagni F; Emili M; Uguagliati B; Bonasoni MP; Bartesaghi R Brain Pathol; 2018 Nov; 28(6):986-998. PubMed ID: 29509279 [TBL] [Abstract][Full Text] [Related]
15. Dynamics of microglial activation in the spinal cord after cerebral infarction are revealed by expression of MHC class II antigen. Schmitt AB; Brook GA; Buss A; Nacimiento W; Noth J; Kreutzberg GW Neuropathol Appl Neurobiol; 1998 Jun; 24(3):167-76. PubMed ID: 9717181 [TBL] [Abstract][Full Text] [Related]
16. OLIG2 Drives Abnormal Neurodevelopmental Phenotypes in Human iPSC-Based Organoid and Chimeric Mouse Models of Down Syndrome. Xu R; Brawner AT; Li S; Liu JJ; Kim H; Xue H; Pang ZP; Kim WY; Hart RP; Liu Y; Jiang P Cell Stem Cell; 2019 Jun; 24(6):908-926.e8. PubMed ID: 31130512 [TBL] [Abstract][Full Text] [Related]
17. Expression of glial cell line-derived neurotrophic factor (GDNF) in the developing human fetal brain. Koo H; Choi BH Int J Dev Neurosci; 2001 Oct; 19(6):549-58. PubMed ID: 11600317 [TBL] [Abstract][Full Text] [Related]
18. Neuroanatomical alterations in higher-order thalamic nuclei of fetuses with Down syndrome. Stagni F; Giacomini A; Emili M; Uguagliati B; Bonasoni MP; Bartesaghi R; Guidi S Clin Neurol Neurosurg; 2020 Jul; 194():105870. PubMed ID: 32480293 [TBL] [Abstract][Full Text] [Related]
19. Growth and development of the brain in Down syndrome. Becker L; Mito T; Takashima S; Onodera K Prog Clin Biol Res; 1991; 373():133-52. PubMed ID: 1838182 [TBL] [Abstract][Full Text] [Related]